+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Epilepsy Market and Competitive Landscape - 2020

  • ID: 5023525
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Epilepsy Market and Competitive Landscape - 2020, provides comprehensive insights into the Epilepsy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Epilepsy market size and drug sales. It also provides insights into Epilepsy epidemiology and late stage pipeline.

This research covers the following: Epilepsy treatment options, Epilepsy late stage clinical trials pipeline, Epilepsy prevalence by countries, Epilepsy market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Epilepsy pipeline: Find out drugs in clinical trials for the treatment of Epilepsy by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Epilepsy epidemiology: Find out the number of patients diagnosed (prevalence) with Epilepsy by countries
  • Epilepsy drugs: Identify key drugs marketed and prescribed for Epilepsy in the US, including trade name, molecule name, and company
  • Epilepsy drugs sales: Find out the sales value for Epilepsy drugs by countries
  • Epilepsy market valuations: Find out the market size for Epilepsy drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Epilepsy drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Epilepsy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Epilepsy market
  • Develop in-depth knowledge of competition and markets
  • Analyze Epilepsy drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Epilepsy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Epilepsy Treatment Options

2. Epilepsy Pipeline Insights
2.1. Epilepsy Phase 3 Clinical Trials
2.2. Epilepsy Phase 2 Clinical Trials
2.3. Epilepsy Phase 1 Clinical Trials

3. Epilepsy Epidemiology Analysis by Countries

4. Germany Epilepsy Market Insights
4.1. Marketed Drugs for Epilepsy in Germany
4.2. Germany Epilepsy Market Size & Forecast
4.3. Germany Epilepsy Drugs Sales Forecast
4.4. Germany Epilepsy Market Share Analysis

5. France Epilepsy Market Insights
5.1. Marketed Drugs for Epilepsy in France
5.2. France Epilepsy Market Size & Forecast
5.3. France Epilepsy Product Sales Forecast
5.4. France Epilepsy Market Share Analysis

6. Italy Epilepsy Market Insights
6.1. Marketed Drugs for Epilepsy in Italy
6.2. Italy Epilepsy Market Size & Forecast
6.3. Italy Epilepsy Product Sales Forecast
6.4. Italy Epilepsy Market Share Analysis

7. Spain Epilepsy Market Insights
7.1. Marketed Drugs for Epilepsy in Spain
7.2. Spain Epilepsy Market Size & Forecast
7.3. Spain Epilepsy Product Sales Forecast
7.4. Spain Epilepsy Market Share Analysis

8. UK Epilepsy Market Insights
8.1. Marketed Drugs for Epilepsy in UK
8.2. UK Epilepsy Market Size & Forecast
8.3. UK Epilepsy Product Sales Forecast
8.4. UK Epilepsy Market Share Analysis

9. Europe Epilepsy Market Insights
9.1. Europe Epilepsy Market Size & Forecast
9.2. Europe Epilepsy Product Sales Forecast
9.3. Europe Epilepsy Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Epilepsy Phase 3 Clinical Trials, Global, 2020
Table 2: Epilepsy Phase 2 Clinical Trials, Global, 2020
Table 3: Epilepsy Phase 1 Clinical Trials, Global, 2020
Table 4: Epilepsy Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Epilepsy in Germany, 2019
Table 6: Germany Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Epilepsy Product Sales ($mn), 2016 - 2024
Table 8: Germany Epilepsy Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Epilepsy in France, 2019
Table 10: France Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Epilepsy Product Sales ($mn), 2016 - 2024
Table 12: France Epilepsy Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Epilepsy in Italy, 2019
Table 14: Italy Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Epilepsy Product Sales ($mn), 2016 - 2024
Table 16: Italy Epilepsy Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Epilepsy in Spain, 2019
Table 18: Spain Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Epilepsy Product Sales ($mn), 2016 - 2024
Table 20: Spain Epilepsy Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Epilepsy in UK, 2019
Table 22: UK Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Epilepsy Product Sales ($mn), 2016 - 2024
Table 24: UK Epilepsy Market Events and Trends, 2016 - 2024
Table 25: Europe Epilepsy Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Epilepsy Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Epilepsy Pipeline by Phase (%), Global, 2020
Figure 2: Epilepsy Prevalence by Countries, 2016 - 2024
Figure 3: Germany Epilepsy Market Size ($mn), 2016 - 2024
Figure 4: Germany Epilepsy Product Sales ($mn), 2016 - 2024
Figure 5: Germany Epilepsy Market Share by Drugs (%), 2019
Figure 6: Germany Epilepsy Market - Future Market Share (%), 2024
Figure 7: France Epilepsy Market Size ($mn), 2016 - 2024
Figure 8: France Epilepsy Product Sales ($mn), 2016 - 2024
Figure 9: France Epilepsy Market Share by Drugs (%), 2019
Figure 10: France Epilepsy Market - Future Market Share (%), 2024
Figure 11: Italy Epilepsy Market Size ($mn), 2016 - 2024
Figure 12: Italy Epilepsy Product Sales ($mn), 2016 - 2024
Figure 13: Italy Epilepsy Market Share by Drugs (%), 2019
Figure 14: Italy Epilepsy Market - Future Market Share (%), 2024
Figure 15: Spain Epilepsy Market Size ($mn), 2016 - 2024
Figure 16: Spain Epilepsy Product Sales ($mn), 2016 - 2024
Figure 17: Spain Epilepsy Market Share by Drugs (%), 2019
Figure 18: Spain Epilepsy Market - Future Market Share (%), 2024
Figure 19: UK Epilepsy Market Size ($mn), 2016 - 2024
Figure 20: UK Epilepsy Product Sales ($mn), 2016 - 2024
Figure 21: UK Epilepsy Market Share by Drugs (%), 2019
Figure 22: UK Epilepsy Market - Future Market Share (%), 2024
Figure 23: Europe Epilepsy Market Size ($mn), 2016 - 2024
Figure 24: Europe Epilepsy Product Sales ($mn), 2016 - 2024
Figure 25: Europe Epilepsy Market Share by Drugs (%), 2019
Figure 26: Europe Epilepsy Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll